Cardior Pharmaceuticals GmbH
|Head of Research and Development
Germany
→
Work
Publications
Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF-REVERT trial.
European journal of heart failure
journal-article
Development of a Mechanism-Based Next-Generation Therapeutic for Heart Failure Derived From the Dark Genome.
JACC. Basic to translational science
journal-article
AAV capsid engineering identified two novel variants with improved in vivo tropism for cardiomyocytes.
Molecular therapy : the journal of the American Society of Gene Therapy
journal-article
ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy.
Circulation. Heart failure
journal-article
AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.
Journal of the American College of Cardiology
journal-article
CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure.
European heart journal
journal-article
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study.
European heart journal
journal-article
Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy.
European heart journal
journal-article
Pleiotropic cardiac functions controlled by ischemia-induced lncRNA H19.
Journal of molecular and cellular cardiology
journal-article
Preclinical development of a miR-132 inhibitor for heart failure treatment.
Nature communications
journal-article
miR-21-KO Alleviates Alveolar Structural Remodeling and Inflammatory Signaling in Acute Lung Injury.
International journal of molecular sciences
journal-article
Structural and functional characterization of the Curli adaptor protein CsgF.
FEBS letters
journal-article
Inhibition of the Cardiac Fibroblast-Enriched lncRNA Meg3 Prevents Cardiac Fibrosis and Diastolic Dysfunction.
Circulation research
journal-article
Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury.
Circulation research
journal-article
Long Noncoding RNAs in Pathological Cardiac Remodeling.
Circulation research
journal-article
Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches.
Physiological reviews
journal-article
Long noncoding RNA Chast promotes cardiac remodeling.
Science translational medicine
journal-article
Long noncoding RNAs as inducers and terminators of vascular development.
Circulation
journal-article
Bioinformatics of cardiovascular miRNA biology.
Journal of molecular and cellular cardiology
journal-article
Impact of a Met(11)Thr single nucleotide polymorphism of surfactant protein D on allergic airway inflammation in a murine asthma model.
Experimental lung research
journal-article
Regulatory RNAs and paracrine networks in the heart.
Cardiovascular research
journal-article
Circulating microRNAs as potential biomarkers of aerobic exercise capacity.
American journal of physiology. Heart and circulatory physiology
journal-article